Ivabradine reduces heart rate in heart failure patients by acting on which specific channel?
- A L-type voltage-gated calcium channel in SA node pacemaker cells
- B Delayed rectifier potassium channel (IKr) prolonging phase 3 repolarisation
- C Fast sodium channel reducing phase 0 depolarisation rate
- D HCN4 channels carrying If (funny current) in SA node pacemaker cells ✓
Explanation
Ivabradine selectively inhibits HCN4 (hyperpolarisation-activated, cyclic nucleotide-gated) channels in the SA node that carry the I(f) or 'funny' pacemaker current. This current is responsible for the slow spontaneous diastolic depolarisation (phase 4) in pacemaker cells; blocking it reduces the slope of depolarisation and decreases heart rate without affecting myocardial contractility or blood pressure. It is used in HFrEF with persistent tachycardia despite beta-blockers.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.